New drug IGT-303 tested for safety in kidney disease patients
Symptom relief
Recruiting now
This study tests the safety of a new drug called IGT-303 in healthy volunteers and people with chronic kidney disease (CKD). About 94 participants will receive either the drug or a placebo, given as a shot under the skin or into a vein. Researchers will monitor for side effects t…
Phase: PHASE1, PHASE2 • Sponsor: Ingenia Therapeutics INC • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC